SUTTON VALENCE GROUP PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: G82229 | MAIDSTONE, ME17 3BD
Showing results 201-250 of 567
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 104 | 43.8K | £764 | -60.6% ▼ | |
| Tibolone | 102 | 4,121 | £561 | +233.3% ▲ |
| Azathioprine | 102 | 6,440 | £159 | -5.9% ▼ |
| Azithromycin | 101 | 1,593 | £548 | -20.3% ▼ |
| Mometasone furoate | 101 | 5,230 | £518 | -24.5% ▼ |
| Clonazepam | 100 | 5,810 | £913 | -35.8% ▼ |
| Sodium valproate | 100 | 10.9K | £2.2K | -68.6% ▼ |
| 99 | 945 | £261 | -52.6% ▼ | |
| Clotrimazole | 98 | 2,910 | £182 | +1.1% vs avg |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 96 | 100 | £4.0K | -42.6% ▼ |
| Other multivitamin preparations | 96 | 2,908 | £639 | -44.4% ▼ |
| Fluticasone/umeclidinium/vilanterol | 95 | 95 | £3.8K | -59.5% ▼ |
| Dulaglutide | 95 | 384 | £6.7K | -17.1% ▼ |
| Dorzolamide | 94 | 2,220 | £1.0K | +13.1% ▲ |
| Nystatin | 93 | 3,870 | £210 | -7.7% ▼ |
| Baclofen | 92 | 18.3K | £226 | -54.1% ▼ |
| Ispaghula husk | 91 | 4,500 | £801 | -30.9% ▼ |
| Fentanyl | 91 | 791 | £2.6K | -11.2% ▼ |
| Isophane insulin | 91 | 578 | £2.5K | -13.8% ▼ |
| Alogliptin | 91 | 2,548 | £2.2K | -64.1% ▼ |
| Pioglitazone hydrochloride | 89 | 2,492 | £139 | +0.6% vs avg |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 87 | 3,536 | £321 | -43.0% ▼ |
| Fusidic acid | 87 | 1,755 | £208 | -31.9% ▼ |
| 87 | 1,222 | £595 | -14.8% ▼ | |
| Betahistine hydrochloride | 86 | 6,934 | £380 | -64.0% ▼ |
| Insulin detemir | 86 | 575 | £4.4K | +9.8% ▲ |
| Dosulepin hydrochloride | 85 | 4,340 | £983 | +50.2% ▲ |
| Modafinil | 85 | 756 | £165 | +307.7% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 85 | 9,422 | £653 | -52.7% ▼ |
| Typhoid | 85 | 85 | £843 | -5.6% ▼ |
| Dutasteride | 83 | 2,482 | £146 | +61.6% ▲ |
| Lercanidipine hydrochloride | 82 | 2,429 | £245 | -86.7% ▼ |
| Triamcinolone acetonide | 81 | 91 | £121 | +8.3% ▲ |
| Cefalexin | 80 | 2,899 | £169 | -31.2% ▼ |
| Chloramphenicol | 80 | 630 | £314 | -30.1% ▼ |
| 80 | 38.8K | £363 | -12.3% ▼ | |
| Saxagliptin | 79 | 1,120 | £1.2K | +136.3% ▲ |
| Exemestane | 79 | 2,370 | £439 | +143.1% ▲ |
| Clobetasol propionate | 79 | 5,905 | £435 | -42.1% ▼ |
| Lidocaine hydrochloride | 79 | 1,526 | £2.1K | -54.2% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 78 | 9,700 | £749 | -48.4% ▼ |
| Light liquid paraffin | 78 | 37.5K | £659 | +129.1% ▲ |
| Carbomer 940/980 | 75 | 1,690 | £302 | -50.7% ▼ |
| 75 | 1,167 | £3.2K | +130.2% ▲ | |
| Pizotifen malate | 73 | 2,548 | £134 | -11.4% ▼ |
| Zonisamide | 73 | 3,388 | £1.7K | +67.3% ▲ |
| Pramipexole | 73 | 6,614 | £336 | -25.6% ▼ |
| Insulin Lispro | 73 | 542 | £3.7K | -4.6% ▼ |
| Biphasic insulin aspart | 73 | 510 | £2.8K | -28.1% ▼ |
| Cinacalcet hydrochloride | 72 | 950 | £217 | +210.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.